<div id="readability-page-1"><p>Verition Fund Management LLC raised its position in  Alignment Healthcare, Inc. (NASDAQ:ALHC - Free Report) by 85.3% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 121,180 shares of the company's stock after buying an additional 55,771 shares during the quarter. Verition Fund Management LLC owned about 0.06% of Alignment Healthcare worth $1,432,000 at the end of the most recent reporting period.</p><div><p><span></span><span>Get <strong>Alignment Healthcare</strong> alerts:</span></p></div><p>A number of other institutional investors have also recently made changes to their positions in ALHC. Deerfield Management Company L.P. Series C raised its stake in  Alignment Healthcare by 31.8% in the 2nd quarter. Deerfield Management Company L.P. Series C now owns 10,901,485 shares of the company's stock valued at $85,250,000 after acquiring an additional 2,630,788 shares during the period.  Hood River Capital Management LLC raised its position in shares of  Alignment Healthcare by 6.4% in the second quarter. Hood River Capital Management LLC now owns 3,106,690 shares of the company's stock valued at $24,294,000 after purchasing an additional 185,854 shares during the period.  William Blair Investment Management LLC lifted its stake in shares of  Alignment Healthcare by 94.4% during the 2nd quarter. William Blair Investment Management LLC now owns 3,104,681 shares of the company's stock valued at $24,279,000 after buying an additional 1,507,759 shares in the last quarter.  Renaissance Technologies LLC boosted its holdings in  Alignment Healthcare by 16.8% in the 2nd quarter. Renaissance Technologies LLC now owns 1,565,800 shares of the company's stock worth $12,245,000 after buying an additional 225,000 shares during the period.  Finally, Charles Schwab Investment Management Inc. grew its stake in  Alignment Healthcare by 1.7% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 839,695 shares of the company's stock valued at $9,925,000 after buying an additional 13,865 shares in the last quarter. Hedge funds and other institutional investors own  86.19% of the company's stock. </p><h2>Alignment Healthcare Price Performance</h2><p>Shares of NASDAQ:ALHC opened at $11.39 on Friday. The company's fifty day moving average price is $11.93 and its 200-day moving average price is $9.91. The company has a debt-to-equity ratio of 1.82, a current ratio of 1.60 and a quick ratio of 1.60. The firm has a market capitalization of $2.18 billion, a price-to-earnings ratio of -15.84 and a beta of 1.42. Alignment Healthcare, Inc. has a one year low of $4.46 and a one year high of $14.25. </p><p>Alignment Healthcare (NASDAQ:ALHC - Get Free Report) last released its earnings results on Tuesday, October 29th. The company reported ($0.14) EPS for the quarter, meeting analysts' consensus estimates of ($0.14). Alignment Healthcare had a negative return on equity of 108.69% and a negative net margin of 5.84%. The business had revenue of $692.43 million for the quarter, compared to analysts' expectations of $662.11 million. During the same quarter in the prior year, the firm earned ($0.19) earnings per share. The firm's revenue was up 51.6% on a year-over-year basis.  On average, equities research analysts anticipate that  Alignment Healthcare, Inc. will post -0.69 earnings per share for the current fiscal year. </p><h2>Insider Buying and Selling at Alignment Healthcare</h2><p>In other Alignment Healthcare news, CFO Robert Thomas Freeman sold 8,561 shares of the business's stock in a transaction on Wednesday, September 11th. The shares were sold at an average price of $10.01, for a total value of $85,695.61. Following the completion of the sale, the chief financial officer now directly owns 399,429 shares of the company's stock, valued at $3,998,284.29. The trade was a 2.10 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Joseph S. Konowiecki sold 6,920 shares of the firm's stock in a transaction dated Monday, November 11th. The shares were sold at an average price of $13.73, for a total value of $95,011.60. Following the transaction, the director now directly owns 1,134,888 shares in the company, valued at $15,582,012.24. This trade represents a 0.61 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 603,057 shares of company stock worth $7,276,931 over the last ninety days. Insiders own  6.60% of the company's stock. </p><h2>Wall Street Analysts Forecast Growth</h2><p>ALHC has been the subject of a number of analyst reports. Robert W. Baird raised their price target on Alignment Healthcare from $10.00 to $11.00 and gave the stock an &#34;outperform&#34; rating in a report on Wednesday, August 14th. KeyCorp assumed coverage on Alignment Healthcare in a research note on Friday, October 11th. They issued a &#34;sector weight&#34; rating for the company. Stephens upgraded Alignment Healthcare from an &#34;equal weight&#34; rating to an &#34;overweight&#34; rating and upped their price target for the company from $13.00 to $17.00 in a research report on Tuesday. UBS Group raised their price objective on shares of Alignment Healthcare from $9.00 to $12.00 and gave the company a &#34;neutral&#34; rating in a research report on Wednesday, October 30th. Finally, Barclays boosted their price objective on shares of Alignment Healthcare from $7.00 to $8.00 and gave the company an &#34;underweight&#34; rating in a research note on Wednesday, October 30th. One research analyst  has rated the stock with a sell rating, two have issued  a hold rating, seven have given a buy rating and two have assigned  a strong buy rating to the stock. Based on data from MarketBeat, Alignment Healthcare presently has a consensus rating of &#34;Moderate Buy&#34; and a consensus price target of $11.44.</p><p><b>Check Out Our Latest Stock Report on ALHC</b></p><h2>Alignment Healthcare Profile</h2> (Free Report)<p>Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.</p><h2>Featured Articles</h2><ul><li>Five stocks we like better than Alignment Healthcare</li><li>Profitably Trade Stocks at 52-Week Highs</li><li>Trinity Capital CEO on Leading Private Credit’s High-Yield Growth</li><li>What is a Secondary Public Offering? What Investors Need to Know</li><li>Lululemon Surges On Q3 Report: Analysts Step in To Support Market</li><li>What is Insider Trading? What You Can Learn from Insider Trading</li><li>10 Safe Investments with High Returns</li></ul><p><strong>Want to see what other hedge funds are holding ALHC?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Alignment Healthcare, Inc. (NASDAQ:ALHC - Free Report).</p><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QUxIQw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QUxIQw"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><p>→ Elon Musk’s chilling warning for humanity <span><span>(From The Freeport Society)</span> <span>(Ad)</span></span><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD0xMDY2Nw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" height="1" width="1" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD0xMDY2Nw"/></p><h2>Should you invest $1,000 in Alignment Healthcare right now?</h2><p>Before you consider Alignment Healthcare, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Alignment Healthcare wasn't on the list.</p><p>While Alignment Healthcare currently has a &#34;Moderate Buy&#34; rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

ALHC

<p>Verition Fund Management LLC increased its stake in Alignment Healthcare, Inc. (NASDAQ:ALHC) by 85.3% in Q3, acquiring 55,771 shares, bringing its total to 121,180 shares valued at approximately $1,432,000. Other institutional investors also raised their positions in ALHC. The company's stock opened at $0.39, with a market cap of $1.18 billion. Alignment Healthcare reported a revenue increase of 51.6% year-over-year, with an EPS of -$0.14 for the last quarter, meeting analysts' expectations. Insiders have sold a total of 603,057 shares in the past 90 days.</p>

Verition Fund Management LLC Purchases 55,771 Shares of Alignment Healthcare, Inc. (NASDAQ:ALHC)